nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—ACHE—prostate cancer	0.719	1	CbGaD
Gallamine Triethiodide—Hypoaesthesia—Docetaxel—prostate cancer	0.000185	0.000818	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Estradiol—prostate cancer	0.000184	0.000814	CcSEcCtD
Gallamine Triethiodide—Asthenia—Conjugated Estrogens—prostate cancer	0.000184	0.000813	CcSEcCtD
Gallamine Triethiodide—Pruritus—Goserelin—prostate cancer	0.000183	0.000809	CcSEcCtD
Gallamine Triethiodide—Pruritus—Conjugated Estrogens—prostate cancer	0.000181	0.000801	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.000181	0.000801	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Capecitabine—prostate cancer	0.000181	0.0008	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Capecitabine—prostate cancer	0.000181	0.000798	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Capecitabine—prostate cancer	0.00018	0.000796	CcSEcCtD
Gallamine Triethiodide—Anaemia—Etoposide—prostate cancer	0.00018	0.000796	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Capecitabine—prostate cancer	0.000179	0.000792	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Estradiol—prostate cancer	0.000177	0.000783	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Goserelin—prostate cancer	0.000177	0.000782	CcSEcCtD
Gallamine Triethiodide—Fatigue—Estradiol—prostate cancer	0.000177	0.000782	CcSEcCtD
Gallamine Triethiodide—Malaise—Etoposide—prostate cancer	0.000176	0.000776	CcSEcCtD
Gallamine Triethiodide—Pain—Estradiol—prostate cancer	0.000175	0.000775	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000175	0.000775	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Etoposide—prostate cancer	0.000174	0.000771	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000174	0.00077	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Docetaxel—prostate cancer	0.000174	0.000768	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Docetaxel—prostate cancer	0.000173	0.000763	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Mitoxantrone—prostate cancer	0.000172	0.000759	CcSEcCtD
Gallamine Triethiodide—Cough—Etoposide—prostate cancer	0.00017	0.000751	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Estradiol—prostate cancer	0.000169	0.000747	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Capecitabine—prostate cancer	0.000168	0.000744	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.000168	0.000741	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Capecitabine—prostate cancer	0.000167	0.000739	CcSEcCtD
Gallamine Triethiodide—Chest pain—Etoposide—prostate cancer	0.000166	0.000733	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Epirubicin—prostate cancer	0.000166	0.000732	CcSEcCtD
Gallamine Triethiodide—Fatigue—Mitoxantrone—prostate cancer	0.000165	0.000728	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000165	0.000728	CcSEcCtD
Gallamine Triethiodide—Vomiting—Goserelin—prostate cancer	0.000165	0.000727	CcSEcCtD
Gallamine Triethiodide—Pain—Mitoxantrone—prostate cancer	0.000163	0.000722	CcSEcCtD
Gallamine Triethiodide—Rash—Goserelin—prostate cancer	0.000163	0.000721	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Goserelin—prostate cancer	0.000163	0.00072	CcSEcCtD
Gallamine Triethiodide—Vomiting—Conjugated Estrogens—prostate cancer	0.000163	0.00072	CcSEcCtD
Gallamine Triethiodide—Urticaria—Estradiol—prostate cancer	0.000163	0.00072	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Estradiol—prostate cancer	0.000162	0.000717	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Estradiol—prostate cancer	0.000162	0.000717	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Epirubicin—prostate cancer	0.000162	0.000717	CcSEcCtD
Gallamine Triethiodide—Headache—Goserelin—prostate cancer	0.000162	0.000716	CcSEcCtD
Gallamine Triethiodide—Rash—Conjugated Estrogens—prostate cancer	0.000162	0.000714	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Conjugated Estrogens—prostate cancer	0.000161	0.000714	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Prednisone—prostate cancer	0.000161	0.000712	CcSEcCtD
Gallamine Triethiodide—Headache—Conjugated Estrogens—prostate cancer	0.000161	0.00071	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Prednisone—prostate cancer	0.00016	0.000709	CcSEcCtD
Gallamine Triethiodide—Confusional state—Etoposide—prostate cancer	0.00016	0.000708	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Docetaxel—prostate cancer	0.000159	0.000701	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Mitoxantrone—prostate cancer	0.000157	0.000696	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Etoposide—prostate cancer	0.000156	0.000688	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Etoposide—prostate cancer	0.000155	0.000686	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Epirubicin—prostate cancer	0.000155	0.000686	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Etoposide—prostate cancer	0.000154	0.000682	CcSEcCtD
Gallamine Triethiodide—Nausea—Goserelin—prostate cancer	0.000154	0.000679	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Capecitabine—prostate cancer	0.000153	0.000678	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Doxorubicin—prostate cancer	0.000153	0.000677	CcSEcCtD
Gallamine Triethiodide—Nausea—Conjugated Estrogens—prostate cancer	0.000152	0.000673	CcSEcCtD
Gallamine Triethiodide—Urticaria—Mitoxantrone—prostate cancer	0.000152	0.000671	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Estradiol—prostate cancer	0.000151	0.000668	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Mitoxantrone—prostate cancer	0.000151	0.000668	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Mitoxantrone—prostate cancer	0.000151	0.000668	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Doxorubicin—prostate cancer	0.00015	0.000663	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Prednisone—prostate cancer	0.00015	0.000662	CcSEcCtD
Gallamine Triethiodide—Anaemia—Docetaxel—prostate cancer	0.00015	0.000661	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Epirubicin—prostate cancer	0.000149	0.000658	CcSEcCtD
Gallamine Triethiodide—Asthenia—Estradiol—prostate cancer	0.000147	0.00065	CcSEcCtD
Gallamine Triethiodide—Pruritus—Estradiol—prostate cancer	0.000145	0.000641	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Docetaxel—prostate cancer	0.000145	0.00064	CcSEcCtD
Gallamine Triethiodide—Anaemia—Capecitabine—prostate cancer	0.000145	0.00064	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Doxorubicin—prostate cancer	0.000144	0.000635	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Etoposide—prostate cancer	0.000143	0.000631	CcSEcCtD
Gallamine Triethiodide—Malaise—Capecitabine—prostate cancer	0.000141	0.000625	CcSEcCtD
Gallamine Triethiodide—Cough—Docetaxel—prostate cancer	0.000141	0.000624	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Mitoxantrone—prostate cancer	0.000141	0.000622	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Estradiol—prostate cancer	0.00014	0.00062	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Capecitabine—prostate cancer	0.00014	0.00062	CcSEcCtD
Gallamine Triethiodide—Chest pain—Docetaxel—prostate cancer	0.000138	0.000609	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Docetaxel—prostate cancer	0.000138	0.000609	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Doxorubicin—prostate cancer	0.000138	0.000609	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Etoposide—prostate cancer	0.000137	0.000607	CcSEcCtD
Gallamine Triethiodide—Asthenia—Mitoxantrone—prostate cancer	0.000137	0.000606	CcSEcCtD
Gallamine Triethiodide—Fatigue—Etoposide—prostate cancer	0.000137	0.000606	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000137	0.000605	CcSEcCtD
Gallamine Triethiodide—Cough—Capecitabine—prostate cancer	0.000137	0.000604	CcSEcCtD
Gallamine Triethiodide—Pain—Etoposide—prostate cancer	0.000136	0.000601	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Capecitabine—prostate cancer	0.000133	0.00059	CcSEcCtD
Gallamine Triethiodide—Chest pain—Capecitabine—prostate cancer	0.000133	0.00059	CcSEcCtD
Gallamine Triethiodide—Confusional state—Docetaxel—prostate cancer	0.000133	0.000589	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000133	0.000586	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Etoposide—prostate cancer	0.000131	0.000579	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Mitoxantrone—prostate cancer	0.000131	0.000578	CcSEcCtD
Gallamine Triethiodide—Vomiting—Estradiol—prostate cancer	0.00013	0.000576	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Docetaxel—prostate cancer	0.000129	0.000572	CcSEcCtD
Gallamine Triethiodide—Rash—Estradiol—prostate cancer	0.000129	0.000572	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Estradiol—prostate cancer	0.000129	0.000571	CcSEcCtD
Gallamine Triethiodide—Anaemia—Prednisone—prostate cancer	0.000129	0.00057	CcSEcCtD
Gallamine Triethiodide—Confusional state—Capecitabine—prostate cancer	0.000129	0.00057	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Docetaxel—prostate cancer	0.000129	0.00057	CcSEcCtD
Gallamine Triethiodide—Headache—Estradiol—prostate cancer	0.000128	0.000568	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Docetaxel—prostate cancer	0.000128	0.000567	CcSEcCtD
Gallamine Triethiodide—Angioedema—Prednisone—prostate cancer	0.000128	0.000564	CcSEcCtD
Gallamine Triethiodide—Urticaria—Etoposide—prostate cancer	0.000126	0.000558	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Epirubicin—prostate cancer	0.000126	0.000557	CcSEcCtD
Gallamine Triethiodide—Malaise—Prednisone—prostate cancer	0.000126	0.000556	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Epirubicin—prostate cancer	0.000126	0.000556	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Etoposide—prostate cancer	0.000126	0.000555	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Etoposide—prostate cancer	0.000126	0.000555	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Epirubicin—prostate cancer	0.000125	0.000554	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Capecitabine—prostate cancer	0.000125	0.000554	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Capecitabine—prostate cancer	0.000125	0.000552	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Epirubicin—prostate cancer	0.000125	0.000552	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Capecitabine—prostate cancer	0.000124	0.000549	CcSEcCtD
Gallamine Triethiodide—Nausea—Estradiol—prostate cancer	0.000122	0.000538	CcSEcCtD
Gallamine Triethiodide—Vomiting—Mitoxantrone—prostate cancer	0.000122	0.000537	CcSEcCtD
Gallamine Triethiodide—Rash—Mitoxantrone—prostate cancer	0.000121	0.000533	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Mitoxantrone—prostate cancer	0.00012	0.000532	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.00012	0.000532	CcSEcCtD
Gallamine Triethiodide—Headache—Mitoxantrone—prostate cancer	0.00012	0.000529	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Prednisone—prostate cancer	0.000119	0.000525	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Docetaxel—prostate cancer	0.000119	0.000524	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000118	0.000522	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Epirubicin—prostate cancer	0.000117	0.000518	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Etoposide—prostate cancer	0.000117	0.000518	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Doxorubicin—prostate cancer	0.000117	0.000516	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000117	0.000515	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Epirubicin—prostate cancer	0.000116	0.000514	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Doxorubicin—prostate cancer	0.000116	0.000514	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Doxorubicin—prostate cancer	0.000116	0.000513	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Doxorubicin—prostate cancer	0.000115	0.00051	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Capecitabine—prostate cancer	0.000115	0.000508	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000114	0.000504	CcSEcCtD
Gallamine Triethiodide—Asthenia—Etoposide—prostate cancer	0.000114	0.000504	CcSEcCtD
Gallamine Triethiodide—Fatigue—Docetaxel—prostate cancer	0.000114	0.000503	CcSEcCtD
Gallamine Triethiodide—Nausea—Mitoxantrone—prostate cancer	0.000114	0.000502	CcSEcCtD
Gallamine Triethiodide—Pain—Docetaxel—prostate cancer	0.000113	0.000499	CcSEcCtD
Gallamine Triethiodide—Pruritus—Etoposide—prostate cancer	0.000112	0.000497	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Prednisone—prostate cancer	0.000111	0.000491	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Prednisone—prostate cancer	0.000111	0.000489	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00011	0.000488	CcSEcCtD
Gallamine Triethiodide—Fatigue—Capecitabine—prostate cancer	0.00011	0.000487	CcSEcCtD
Gallamine Triethiodide—Pain—Capecitabine—prostate cancer	0.000109	0.000483	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Docetaxel—prostate cancer	0.000109	0.000481	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Etoposide—prostate cancer	0.000109	0.000481	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Doxorubicin—prostate cancer	0.000108	0.000479	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Doxorubicin—prostate cancer	0.000108	0.000476	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Epirubicin—prostate cancer	0.000107	0.000473	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Capecitabine—prostate cancer	0.000105	0.000466	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Docetaxel—prostate cancer	0.000104	0.000462	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Docetaxel—prostate cancer	0.000104	0.000462	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000104	0.000459	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Prednisone—prostate cancer	0.000102	0.000452	CcSEcCtD
Gallamine Triethiodide—Urticaria—Capecitabine—prostate cancer	0.000102	0.000449	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Capecitabine—prostate cancer	0.000101	0.000447	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Capecitabine—prostate cancer	0.000101	0.000447	CcSEcCtD
Gallamine Triethiodide—Vomiting—Etoposide—prostate cancer	0.000101	0.000447	CcSEcCtD
Gallamine Triethiodide—Anaemia—Epirubicin—prostate cancer	0.000101	0.000446	CcSEcCtD
Gallamine Triethiodide—Rash—Etoposide—prostate cancer	0.0001	0.000443	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Etoposide—prostate cancer	0.0001	0.000443	CcSEcCtD
Gallamine Triethiodide—Headache—Etoposide—prostate cancer	9.96e-05	0.00044	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Doxorubicin—prostate cancer	9.89e-05	0.000437	CcSEcCtD
Gallamine Triethiodide—Malaise—Epirubicin—prostate cancer	9.85e-05	0.000435	CcSEcCtD
Gallamine Triethiodide—Fatigue—Prednisone—prostate cancer	9.82e-05	0.000434	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Epirubicin—prostate cancer	9.77e-05	0.000432	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Docetaxel—prostate cancer	9.73e-05	0.00043	CcSEcCtD
Gallamine Triethiodide—Cough—Epirubicin—prostate cancer	9.53e-05	0.000421	CcSEcCtD
Gallamine Triethiodide—Asthenia—Docetaxel—prostate cancer	9.48e-05	0.000419	CcSEcCtD
Gallamine Triethiodide—Nausea—Etoposide—prostate cancer	9.44e-05	0.000417	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Capecitabine—prostate cancer	9.42e-05	0.000417	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Prednisone—prostate cancer	9.39e-05	0.000415	CcSEcCtD
Gallamine Triethiodide—Pruritus—Docetaxel—prostate cancer	9.35e-05	0.000413	CcSEcCtD
Gallamine Triethiodide—Anaemia—Doxorubicin—prostate cancer	9.34e-05	0.000413	CcSEcCtD
Gallamine Triethiodide—Chest pain—Epirubicin—prostate cancer	9.3e-05	0.000411	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Epirubicin—prostate cancer	9.3e-05	0.000411	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	9.23e-05	0.000408	CcSEcCtD
Gallamine Triethiodide—Asthenia—Capecitabine—prostate cancer	9.18e-05	0.000406	CcSEcCtD
Gallamine Triethiodide—Malaise—Doxorubicin—prostate cancer	9.11e-05	0.000403	CcSEcCtD
Gallamine Triethiodide—Urticaria—Prednisone—prostate cancer	9.05e-05	0.0004	CcSEcCtD
Gallamine Triethiodide—Pruritus—Capecitabine—prostate cancer	9.05e-05	0.0004	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Doxorubicin—prostate cancer	9.04e-05	0.0004	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Docetaxel—prostate cancer	9.04e-05	0.0004	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Prednisone—prostate cancer	9.01e-05	0.000398	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Prednisone—prostate cancer	9.01e-05	0.000398	CcSEcCtD
Gallamine Triethiodide—Confusional state—Epirubicin—prostate cancer	8.99e-05	0.000397	CcSEcCtD
Gallamine Triethiodide—Cough—Doxorubicin—prostate cancer	8.82e-05	0.00039	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Capecitabine—prostate cancer	8.75e-05	0.000387	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Epirubicin—prostate cancer	8.73e-05	0.000386	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Epirubicin—prostate cancer	8.7e-05	0.000384	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Epirubicin—prostate cancer	8.66e-05	0.000383	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Doxorubicin—prostate cancer	8.6e-05	0.00038	CcSEcCtD
Gallamine Triethiodide—Chest pain—Doxorubicin—prostate cancer	8.6e-05	0.00038	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	8.54e-05	0.000378	CcSEcCtD
Gallamine Triethiodide—Vomiting—Docetaxel—prostate cancer	8.4e-05	0.000371	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Prednisone—prostate cancer	8.39e-05	0.000371	CcSEcCtD
Gallamine Triethiodide—Rash—Docetaxel—prostate cancer	8.33e-05	0.000368	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Docetaxel—prostate cancer	8.32e-05	0.000368	CcSEcCtD
Gallamine Triethiodide—Confusional state—Doxorubicin—prostate cancer	8.31e-05	0.000367	CcSEcCtD
Gallamine Triethiodide—Headache—Docetaxel—prostate cancer	8.28e-05	0.000366	CcSEcCtD
Gallamine Triethiodide—Asthenia—Prednisone—prostate cancer	8.17e-05	0.000361	CcSEcCtD
Gallamine Triethiodide—Vomiting—Capecitabine—prostate cancer	8.13e-05	0.000359	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Epirubicin—prostate cancer	8.12e-05	0.000359	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Doxorubicin—prostate cancer	8.07e-05	0.000357	CcSEcCtD
Gallamine Triethiodide—Rash—Capecitabine—prostate cancer	8.07e-05	0.000356	CcSEcCtD
Gallamine Triethiodide—Pruritus—Prednisone—prostate cancer	8.06e-05	0.000356	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Capecitabine—prostate cancer	8.06e-05	0.000356	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Doxorubicin—prostate cancer	8.05e-05	0.000356	CcSEcCtD
Gallamine Triethiodide—Headache—Capecitabine—prostate cancer	8.01e-05	0.000354	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Doxorubicin—prostate cancer	8.01e-05	0.000354	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Epirubicin—prostate cancer	8e-05	0.000354	CcSEcCtD
Gallamine Triethiodide—Nausea—Docetaxel—prostate cancer	7.85e-05	0.000347	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Prednisone—prostate cancer	7.8e-05	0.000345	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Epirubicin—prostate cancer	7.69e-05	0.00034	CcSEcCtD
Gallamine Triethiodide—Fatigue—Epirubicin—prostate cancer	7.68e-05	0.00034	CcSEcCtD
Gallamine Triethiodide—Pain—Epirubicin—prostate cancer	7.62e-05	0.000337	CcSEcCtD
Gallamine Triethiodide—Nausea—Capecitabine—prostate cancer	7.6e-05	0.000336	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7.51e-05	0.000332	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Doxorubicin—prostate cancer	7.4e-05	0.000327	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Epirubicin—prostate cancer	7.34e-05	0.000325	CcSEcCtD
Gallamine Triethiodide—Vomiting—Prednisone—prostate cancer	7.24e-05	0.00032	CcSEcCtD
Gallamine Triethiodide—Rash—Prednisone—prostate cancer	7.18e-05	0.000318	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Prednisone—prostate cancer	7.18e-05	0.000317	CcSEcCtD
Gallamine Triethiodide—Headache—Prednisone—prostate cancer	7.14e-05	0.000315	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.12e-05	0.000315	CcSEcCtD
Gallamine Triethiodide—Fatigue—Doxorubicin—prostate cancer	7.11e-05	0.000314	CcSEcCtD
Gallamine Triethiodide—Urticaria—Epirubicin—prostate cancer	7.08e-05	0.000313	CcSEcCtD
Gallamine Triethiodide—Pain—Doxorubicin—prostate cancer	7.05e-05	0.000312	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Epirubicin—prostate cancer	7.04e-05	0.000311	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Epirubicin—prostate cancer	7.04e-05	0.000311	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Doxorubicin—prostate cancer	6.79e-05	0.0003	CcSEcCtD
Gallamine Triethiodide—Nausea—Prednisone—prostate cancer	6.77e-05	0.000299	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Epirubicin—prostate cancer	6.57e-05	0.00029	CcSEcCtD
Gallamine Triethiodide—Urticaria—Doxorubicin—prostate cancer	6.55e-05	0.00029	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Doxorubicin—prostate cancer	6.52e-05	0.000288	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Doxorubicin—prostate cancer	6.52e-05	0.000288	CcSEcCtD
Gallamine Triethiodide—Asthenia—Epirubicin—prostate cancer	6.39e-05	0.000283	CcSEcCtD
Gallamine Triethiodide—Pruritus—Epirubicin—prostate cancer	6.3e-05	0.000279	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Epirubicin—prostate cancer	6.1e-05	0.000269	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Doxorubicin—prostate cancer	6.07e-05	0.000268	CcSEcCtD
Gallamine Triethiodide—Asthenia—Doxorubicin—prostate cancer	5.92e-05	0.000261	CcSEcCtD
Gallamine Triethiodide—Pruritus—Doxorubicin—prostate cancer	5.83e-05	0.000258	CcSEcCtD
Gallamine Triethiodide—Vomiting—Epirubicin—prostate cancer	5.67e-05	0.00025	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Doxorubicin—prostate cancer	5.64e-05	0.000249	CcSEcCtD
Gallamine Triethiodide—Rash—Epirubicin—prostate cancer	5.62e-05	0.000248	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Epirubicin—prostate cancer	5.61e-05	0.000248	CcSEcCtD
Gallamine Triethiodide—Headache—Epirubicin—prostate cancer	5.58e-05	0.000247	CcSEcCtD
Gallamine Triethiodide—Nausea—Epirubicin—prostate cancer	5.29e-05	0.000234	CcSEcCtD
Gallamine Triethiodide—Vomiting—Doxorubicin—prostate cancer	5.24e-05	0.000232	CcSEcCtD
Gallamine Triethiodide—Rash—Doxorubicin—prostate cancer	5.2e-05	0.00023	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Doxorubicin—prostate cancer	5.19e-05	0.00023	CcSEcCtD
Gallamine Triethiodide—Headache—Doxorubicin—prostate cancer	5.17e-05	0.000228	CcSEcCtD
Gallamine Triethiodide—Nausea—Doxorubicin—prostate cancer	4.9e-05	0.000216	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PLAUR—prostate cancer	3.98e-05	0.000724	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PENK—prostate cancer	3.95e-05	0.000718	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HSD3B1—prostate cancer	3.92e-05	0.000713	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC22A3—prostate cancer	3.92e-05	0.000713	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CASP3—prostate cancer	3.88e-05	0.000705	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LPL—prostate cancer	3.8e-05	0.000691	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	3.79e-05	0.000689	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	3.78e-05	0.000687	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTA4—prostate cancer	3.76e-05	0.000683	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TBXAS1—prostate cancer	3.76e-05	0.000683	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	3.74e-05	0.00068	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	3.71e-05	0.000674	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GNRH1—prostate cancer	3.7e-05	0.000673	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—VIP—prostate cancer	3.7e-05	0.000673	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.67e-05	0.000668	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTA2—prostate cancer	3.66e-05	0.000666	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRB2—prostate cancer	3.66e-05	0.000665	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RLN2—prostate cancer	3.62e-05	0.000658	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SULT1A1—prostate cancer	3.62e-05	0.000658	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCG5—prostate cancer	3.62e-05	0.000658	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—LPAR1—prostate cancer	3.58e-05	0.000651	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRP—prostate cancer	3.58e-05	0.000651	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PLCB2—prostate cancer	3.55e-05	0.000645	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTA1—prostate cancer	3.53e-05	0.000642	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	3.5e-05	0.000637	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NAT2—prostate cancer	3.5e-05	0.000635	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTO1—prostate cancer	3.5e-05	0.000635	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HSD3B2—prostate cancer	3.5e-05	0.000635	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—EP300—prostate cancer	3.48e-05	0.000632	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CTBP2—prostate cancer	3.46e-05	0.000628	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HSD17B1—prostate cancer	3.46e-05	0.000628	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PDE4D—prostate cancer	3.38e-05	0.000615	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—VIP—prostate cancer	3.36e-05	0.000611	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNRH1—prostate cancer	3.36e-05	0.000611	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.36e-05	0.000611	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLCB2—prostate cancer	3.35e-05	0.000609	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LRP2—prostate cancer	3.35e-05	0.000609	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2C18—prostate cancer	3.35e-05	0.000609	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLXNB1—prostate cancer	3.31e-05	0.000602	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—prostate cancer	3.29e-05	0.000598	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—P4HB—prostate cancer	3.29e-05	0.000597	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—LPAR1—prostate cancer	3.25e-05	0.000591	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRP—prostate cancer	3.25e-05	0.000591	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PLCB2—prostate cancer	3.22e-05	0.000586	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GNG5—prostate cancer	3.22e-05	0.000585	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	3.22e-05	0.000585	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC22A1—prostate cancer	3.2e-05	0.000581	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRPR—prostate cancer	3.19e-05	0.00058	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CX3CL1—prostate cancer	3.16e-05	0.000574	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.16e-05	0.000574	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SULT2A1—prostate cancer	3.12e-05	0.000566	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	3.11e-05	0.000566	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL17RD—prostate cancer	3.08e-05	0.00056	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PDE4D—prostate cancer	3.07e-05	0.000559	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—prostate cancer	3.07e-05	0.000559	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MED12—prostate cancer	3.06e-05	0.000557	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GNG5—prostate cancer	3.04e-05	0.000553	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOA3—prostate cancer	2.93e-05	0.000532	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNG5—prostate cancer	2.92e-05	0.000531	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL8—prostate cancer	2.92e-05	0.000531	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—prostate cancer	2.9e-05	0.000528	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.88e-05	0.000523	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PTHLH—prostate cancer	2.8e-05	0.00051	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HPGDS—prostate cancer	2.79e-05	0.000508	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2C19—prostate cancer	2.78e-05	0.000505	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LEP—prostate cancer	2.76e-05	0.000501	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—WNT4—prostate cancer	2.75e-05	0.000499	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JUP—prostate cancer	2.75e-05	0.000499	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTT1—prostate cancer	2.71e-05	0.000492	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2A6—prostate cancer	2.68e-05	0.000487	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.67e-05	0.000485	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—prostate cancer	2.67e-05	0.000485	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ANXA1—prostate cancer	2.64e-05	0.000479	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.63e-05	0.000478	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MC2R—prostate cancer	2.62e-05	0.000476	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RALBP1—prostate cancer	2.62e-05	0.000476	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKR1C3—prostate cancer	2.61e-05	0.000474	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PRKACB—prostate cancer	2.59e-05	0.000471	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP17A1—prostate cancer	2.57e-05	0.000466	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTHLH—prostate cancer	2.55e-05	0.000463	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.53e-05	0.00046	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKACB—prostate cancer	2.49e-05	0.000453	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CALCA—prostate cancer	2.47e-05	0.000449	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOA2—prostate cancer	2.44e-05	0.000444	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PPP3CA—prostate cancer	2.43e-05	0.000442	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL12—prostate cancer	2.41e-05	0.000438	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ANXA1—prostate cancer	2.39e-05	0.000435	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—INS—prostate cancer	2.35e-05	0.000428	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PENK—prostate cancer	2.33e-05	0.000424	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC5A5—prostate cancer	2.33e-05	0.000424	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	2.32e-05	0.000422	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2E1—prostate cancer	2.28e-05	0.000414	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—prostate cancer	2.28e-05	0.000414	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF1—prostate cancer	2.28e-05	0.000414	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NQO1—prostate cancer	2.25e-05	0.000409	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CALCA—prostate cancer	2.24e-05	0.000407	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GHR—prostate cancer	2.23e-05	0.000405	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TH—prostate cancer	2.22e-05	0.000403	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.21e-05	0.000401	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP2—prostate cancer	2.2e-05	0.0004	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PRKCQ—prostate cancer	2.2e-05	0.0004	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP3A4—prostate cancer	2.2e-05	0.000399	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL12—prostate cancer	2.19e-05	0.000398	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.19e-05	0.000397	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1B1—prostate cancer	2.16e-05	0.000392	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRP1—prostate cancer	2.14e-05	0.000388	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GGT1—prostate cancer	2.09e-05	0.00038	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB2—prostate cancer	2.07e-05	0.000376	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOA1—prostate cancer	2.06e-05	0.000374	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP19A1—prostate cancer	2.03e-05	0.000369	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—VAV3—prostate cancer	2.02e-05	0.000367	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKCQ—prostate cancer	2e-05	0.000363	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VIP—prostate cancer	1.99e-05	0.000361	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNRH1—prostate cancer	1.99e-05	0.000361	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—RXRA—prostate cancer	1.96e-05	0.000356	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ITPR1—prostate cancer	1.96e-05	0.000356	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LPAR1—prostate cancer	1.92e-05	0.000349	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRP—prostate cancer	1.92e-05	0.000349	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.91e-05	0.000346	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLCB2—prostate cancer	1.9e-05	0.000346	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LRP2—prostate cancer	1.9e-05	0.000346	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—COMT—prostate cancer	1.89e-05	0.000343	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB2—prostate cancer	1.88e-05	0.000341	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTP1—prostate cancer	1.88e-05	0.000341	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—P4HB—prostate cancer	1.87e-05	0.000339	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CX3CL1—prostate cancer	1.87e-05	0.000339	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ITPR1—prostate cancer	1.85e-05	0.000336	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—VAV3—prostate cancer	1.83e-05	0.000333	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HIST1H2BG—prostate cancer	1.83e-05	0.000333	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CXCL8—prostate cancer	1.83e-05	0.000333	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.82e-05	0.00033	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRB7—prostate cancer	1.82e-05	0.00033	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDE4D—prostate cancer	1.82e-05	0.00033	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ITPR1—prostate cancer	1.78e-05	0.000323	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HIST1H4H—prostate cancer	1.77e-05	0.000322	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL8—prostate cancer	1.77e-05	0.000321	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TYMS—prostate cancer	1.75e-05	0.000317	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNG5—prostate cancer	1.73e-05	0.000314	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTM1—prostate cancer	1.73e-05	0.000314	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPL—prostate cancer	1.69e-05	0.000308	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CTNNB1—prostate cancer	1.69e-05	0.000307	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1A1—prostate cancer	1.64e-05	0.000297	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ERCC2—prostate cancer	1.62e-05	0.000295	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTHFR—prostate cancer	1.53e-05	0.000277	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTHLH—prostate cancer	1.5e-05	0.000273	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFBR1—prostate cancer	1.5e-05	0.000273	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARA—prostate cancer	1.5e-05	0.000272	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKR1C3—prostate cancer	1.48e-05	0.000269	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKACB—prostate cancer	1.47e-05	0.000268	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—THBS1—prostate cancer	1.44e-05	0.000261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPP3CA—prostate cancer	1.44e-05	0.000261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ANXA1—prostate cancer	1.41e-05	0.000257	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CAV1—prostate cancer	1.41e-05	0.000256	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCZ—prostate cancer	1.39e-05	0.000252	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CG—prostate cancer	1.36e-05	0.000247	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.34e-05	0.000244	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PARP1—prostate cancer	1.34e-05	0.000244	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGFR4—prostate cancer	1.34e-05	0.000244	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CALCA—prostate cancer	1.32e-05	0.000241	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL12—prostate cancer	1.29e-05	0.000235	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CG—prostate cancer	1.28e-05	0.000233	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CG—prostate cancer	1.23e-05	0.000224	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP9—prostate cancer	1.22e-05	0.000221	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—INS—prostate cancer	1.21e-05	0.00022	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CD—prostate cancer	1.19e-05	0.000217	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CREBBP—prostate cancer	1.19e-05	0.000216	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCQ—prostate cancer	1.18e-05	0.000215	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NGFR—prostate cancer	1.18e-05	0.000215	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAP3K7—prostate cancer	1.17e-05	0.000212	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CD—prostate cancer	1.13e-05	0.000205	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF10—prostate cancer	1.12e-05	0.000204	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB2—prostate cancer	1.11e-05	0.000202	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—JAK2—prostate cancer	1.1e-05	0.000199	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAP2K1—prostate cancer	1.09e-05	0.000198	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CD—prostate cancer	1.08e-05	0.000197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VAV3—prostate cancer	1.08e-05	0.000197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	1.07e-05	0.000194	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NOS3—prostate cancer	1.06e-05	0.000193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ITPR1—prostate cancer	1.05e-05	0.000191	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	1.04e-05	0.000189	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1R—prostate cancer	1e-05	0.000182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	9.99e-06	0.000182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—JAK2—prostate cancer	9.94e-06	0.000181	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CB—prostate cancer	9.82e-06	0.000178	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—prostate cancer	9.73e-06	0.000177	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LPL—prostate cancer	9.62e-06	0.000175	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IL2—prostate cancer	9.55e-06	0.000174	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	9.54e-06	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	9.44e-06	0.000172	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ITGB3—prostate cancer	9.3e-06	0.000169	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	9.08e-06	0.000165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB3—prostate cancer	9.02e-06	0.000164	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGFR2—prostate cancer	9e-06	0.000164	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL2—prostate cancer	8.67e-06	0.000158	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TERT—prostate cancer	8.64e-06	0.000157	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTEN—prostate cancer	8.49e-06	0.000154	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HIF1A—prostate cancer	8.26e-06	0.00015	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—EP300—prostate cancer	8.09e-06	0.000147	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEP—prostate cancer	8.07e-06	0.000147	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CAV1—prostate cancer	7.99e-06	0.000145	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KDR—prostate cancer	7.9e-06	0.000144	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ESR1—prostate cancer	7.7e-06	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BAD—prostate cancer	7.52e-06	0.000137	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APC—prostate cancer	7.28e-06	0.000132	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	7.28e-06	0.000132	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGF—prostate cancer	7.2e-06	0.000131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IRS1—prostate cancer	7.2e-06	0.000131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GSK3B—prostate cancer	6.99e-06	0.000127	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INS—prostate cancer	6.89e-06	0.000125	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CREBBP—prostate cancer	6.75e-06	0.000123	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1—prostate cancer	6.67e-06	0.000121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EGFR—prostate cancer	6.63e-06	0.000121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	6.44e-06	0.000117	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	6.4e-06	0.000116	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	6.34e-06	0.000115	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	6.33e-06	0.000115	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KRAS—prostate cancer	6.27e-06	0.000114	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF2—prostate cancer	6.13e-06	0.000111	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOS3—prostate cancer	6.04e-06	0.00011	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CA—prostate cancer	5.99e-06	0.000109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JAK2—prostate cancer	5.87e-06	0.000107	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	5.76e-06	0.000105	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MDM2—prostate cancer	5.73e-06	0.000104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB2—prostate cancer	5.65e-06	0.000103	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	5.58e-06	0.000101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL8—prostate cancer	5.36e-06	9.74e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	5.24e-06	9.51e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	5.18e-06	9.41e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP3—prostate cancer	5.13e-06	9.32e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL2—prostate cancer	5.12e-06	9.31e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—prostate cancer	5.1e-06	9.26e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCND1—prostate cancer	4.99e-06	9.08e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	4.95e-06	8.99e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—prostate cancer	4.89e-06	8.89e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—prostate cancer	4.85e-06	8.81e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	4.83e-06	8.78e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTEN—prostate cancer	4.82e-06	8.76e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—prostate cancer	4.7e-06	8.55e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EP300—prostate cancer	4.6e-06	8.35e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SRC—prostate cancer	4.47e-06	8.12e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—prostate cancer	4.35e-06	7.91e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT3—prostate cancer	4.31e-06	7.83e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MYC—prostate cancer	4.01e-06	7.28e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—prostate cancer	4e-06	7.26e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGFR—prostate cancer	3.92e-06	7.12e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KRAS—prostate cancer	3.7e-06	6.73e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	3.4e-06	6.18e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TP53—prostate cancer	3.29e-06	5.98e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—prostate cancer	3.01e-06	5.47e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—prostate cancer	2.78e-06	5.05e-05	CbGpPWpGaD
